Physician profile
Peily Soong
NPI 1467477562
$1,521.17
in general payments reported to CMS, 2019-2025
19 companies · $438 in 2025
The $438 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $91.58 · 2021: $57.63 · 2022: $143 · 2023: $246 · 2024: $173 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $384.17 | 2022-2025 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $126.28 | 2025 | Neffy |
| Pfizer INC. | $121.97 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $111.58 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.30 | 2019-2022 | |
| Sanofi Pasteur INC. | $104.89 | 2019-2025 | |
| Glaxosmithkline, LLC. | $91.22 | 2019-2023 | Bexsero |
| Ironshore Pharmaceuticals INC. | $80.49 | 2019 | |
| Supernus Pharmaceuticals, INC. | $64.95 | 2020-2022 | |
| Sobi, INC | $60.30 | 2019-2023 | |
| Neos Therapeutics, LP | $59.60 | 2019-2020 | |
| Seqirus USA INC | $39.95 | 2024-2025 | Fluad, Flucelvax |
| Verrica Pharmaceuticals INC. | $36.85 | 2024-2025 | Ycanth |
| Astrazeneca Pharmaceuticals LP | $30.64 | 2022-2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $26.24 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $26.22 | 2019 | |
| Shire North American Group INC | $17.63 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.73 | 2025 | Relexxii |
| Kaleo, INC. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peily Soong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.